Actively Recruiting
Study of Antibiotic Treatment Effects After Two-stage Revision Surgery for Prosthetic Joint Infection
Led by First Affiliated Hospital of Fujian Medical University · Updated on 2022-03-17
500
Participants Needed
1
Research Sites
156 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a multicenter prospective cohort study to evaluate the effects of antibiotic treatment duration on patients undergoing two-stage revision surgery for prosthetic joint infection PJI. The study focuses on patients diagnosed with PJI based on MSIS criteria who have already received spacer implantation and a full course of antibiotics. The goal is to analyze infection control rates following these treatments and better understand the outcomes after secondary joint revision surgery. Eligible patients receive intravenous antibiotic treatment for 2 weeks after the first stage, followed by decisions on continued antibiotic use by the attending physician, tailored to each patients condition. The study includes a follow-up period with clinical evaluations at 1, 3, 6, 12, 18, and 24 months after starting antibiotic treatment post-secondary revision. All participants have signed informed consent forms prior to inclusion. During the study, patients undergo regular clinical assessments to monitor infection control and overall health. Researchers will evaluate the primary outcome of infection clearance rate at least 2 years after surgery. The study aims to gather detailed data on the antibiotic treatment course and its relationship with long-term infection control. Participants progress and response to treatment are closely observed throughout the follow-up period until the study ends in late 2026.
CONDITIONS
Brief Title
Prospective Cohort Study on Antibiotic Course and Efficacy After Two-stage Revision in PJI.
Research Team
F
Fang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here